Elevated expression of FGF7 protein is common in human gastric diseases

Biochemical and Biophysical Research Communications

Volumn 350, Issue 4, 2006, Pages 825-833

  Shaoul, Ron ^a   Eliahu, Liat ^a   Sher, Ifat ^a   Hamlet, Yaheli ^a   Miselevich, Ines ^b   Goldshmidt, Orit ^a   Ron, Dina ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Anti sense RNA; FGF7; Fibroblast growth factor; Gastric diseases; Helicobacter pylori

Indexed keywords

KERATINOCYTE GROWTH FACTOR; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; GASTRITIS; HUMAN; HUMAN TISSUE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH; STOMACH ADENOCARCINOMA; STOMACH DISEASE; STOMACH MUCOSA;

ADENOCARCINOMA; FIBROBLAST GROWTH FACTOR 7; GASTRITIS; GENE EXPRESSION; HUMANS; NEOPLASM PROTEINS; STOMACH; STOMACH DISEASES; STOMACH NEOPLASMS; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

HELICOBACTER PYLORI;

EID: 33751006437     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.08.198     Document Type: Article

References (44)

1. T.J. Koh, T.C. Wang, Tumors of the stomach, in: M. Feldman, W.O. Tschumy, L.S. Friedman, M.H. Sleisenger (Eds.), Sleisenger & Fordtran's Gastrointestinal and Liver Disease, 2002, pp. 829-856.
2. Smith M.G., Hold G.L., Tahara E., and El-Omar E.M. Cellular and molecular aspects of gastric cancer. World J. Gastroenterol. 12 (2006) 2979-2990
3. Stoicov C., Saffari R., Cai X., Hasyagar C., and Houghton J. Molecular biology of gastric cancer: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling. Gene 341 (2004) 1-17
4. Ohshima H., Tazawa H., Sylla B.S., and Sawa T. Prevention of human cancer by modulation of chronic inflammatory processes. Mutat. Res. 591 (2005) 110-122
5. Becker J.C., Muller-Tidow C., Serve H., Domschke W., and Pohle T. Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy. World J. Gastroenterol. 12 (2006) 3297-3305
6. Finch P.W., and Rubin J.S. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv. Cancer Res. 91 (2004) 69-136
7. Housley R.M., Morris C.F., Boyle W., Ring B., Biltz R., Tarpley J.E., Aukerman S.L., Devine P.L., Whitehead R.H., and Pierce G.F. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J. Clin. Invest. 94 (1994) 1764-1777
8. Iida S., Katoh O., Tokunaga A., and Terada M. Expression of fibroblast growth factor gene family and its receptor gene family in the human upper gastrointestinal tract. Biochem. Biophys. Res. Commun. 199 (1994) 1113-1119
9. Finch P.W., Pricolo V., Wu A., and Finkelstein S.D. Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease. Gastroenterology 110 (1996) 441-451
10. Brauchle M., Madlener M., Wagner A.D., Angermeyer K., Lauer U., Hofschneider P.H., Gregor M., and Werner S. Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am. J. Pathol. 149 (1996) 521-529
11. Matsubara Y., Ichinose M., Tatematsu M., Ichinose M., Oka M., Yahagi N., Kurokawa K., Kageyama T., Miki K., and Fukamachi H. Stage-specific elevated expression of the genes for hepatocyte growth factor, keratinocyte growth factor, and their receptors during the morphogenesis and differentiation of rat stomach mucosa. Biochem. Biophys. Res. Commun. 222 (1996) 669-677
12. Kinoshita Y., Nakata H., Hassan S., Asahara M., Kawanami C., Matsushima Y., Naribayashi-Inomoto Y., Ping C.Y., Min D., and Nakamura A. Gene expression of keratinocyte and hepatocyte growth factors during the healing of rat gastric mucosal lesions. Gastroenterology 109 (1995) 1068-1077
13. Chailler P., Basque J.R., Corriveau L., and Menard D. Functional characterization of the keratinocyte growth factor system in human fetal gastrointestinal tract. Pediatr. Res. 48 (2000) 504-510
14. Nakazawa K., Yashiro M., and Hirakawa K. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Cancer Res. 63 (2003) 8848-8852
15. Ron D., Bottaro D.P., Finch P.W., Morris D., Rubin J.S., and Aaronson S.A. Expression of biologically active recombinant keratinocyte growth factor. Structure/function analysis of amino-terminal truncation mutants. J. Biol. Chem. 268 (1993) 2984-2988
16. Dixon M.F., Genta R.M., Yardley J.H., and Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20 (1996) 1161-1181
17. Finch P.W., Rubin J.S., Miki T., Ron D., and Aaronson S.A. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245 (1989) 752-755
18. Ishiwata T., Friess H., Buchler M.W., Lopez M.E., and Korc M. Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am. J. Pathol. 153 (1998) 213-222
19. Eisemann A., Ahn J.A., Graziani G., Tronick S.R., and Ron D. Alternative splicing generates at least five different isoforms of the human basic-FGF receptor. Oncogene 6 (1991) 1195-1202
20. Murdoch A.D., Liu B., Schwarting R., Tuan R.S., and Iozzo R.V. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J. Histochem. Cytochem. 42 (1994) 239-249
21. Arikawa-Hirasawa E., Wilcox W.R., Le A.H., Silverman N., Govindraj P., Hassell J.R., and Yamada Y. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene. Nat. Genet. 27 (2001) 431-434
22. Arikawa-Hirasawa E., Watanabe H., Takami H., Hassell J.R., and Yamada Y. Perlecan is essential for cartilage and cephalic development. Nat. Genet. 23 (1999) 354-358
23. Watanabe M., Ishiwata T., Nishigai K., Moriyama Y., and Asano G. Overexpression of keratinocyte growth factor in cancer cells and enterochromaffin cells in human colorectal cancer. Pathol. Int. 50 (2000) 363-372
24. Mason I.J., Fuller-Pace F., Smith R., and Dickson C. FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions. Mech. Dev. 45 (1994) 15-30
25. Finch P.W., Cunha G.R., Rubin J.S., Wong J., and Ron D. Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev. Dyn. 203 (1995) 223-240
26. Ka H., Spencer T.E., Johnson G.A., and Bazer F.W. Keratinocyte growth factor: expression by endometrial epithelia of the porcine uterus. Biol. Reprod. 62 (2000) 1772-1778
27. Weng J., Liang Q., Mohan R.R., Li Q., and Wilson S.E. Hepatocyte growth factor, keratinocyte growth factor, and other growth factor-receptor systems in the lens. Invest. Ophthalmol. Vis. Sci. 38 (1997) 1543-1554
28. Brauchle M., Angermeyer K., Hubner G., and Werner S. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene 9 (1994) 3199-3204
29. Chedid M., Rubin J.S., Csaky K.G., and Aaronson S.A. Regulation of keratinocyte growth factor gene expression by interleukin 1. J. Biol. Chem. 269 (1994) 10753-10757
30. Finch P.W., Lengel C., and Chedid M. Cloning and characterization of the promoter region of the human keratinocyte growth factor gene. J. Biol. Chem. 270 (1995) 11230-11237
31. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
32. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
33. Hattori Y., Itoh H., Uchino S., Hosokawa K., Ochiai A., Ino Y., Ishii H., Sakamoto H., Yamaguchi N., Yanagihara K., Hirohashi S., Sugimura T., and Terada M. Immunohistochemical detection of K-sam protein in stomach cancer. Clin. Cancer Res. 2 (1996) 1373-1381
34. Ishii H., Yoshida T., Oh H., Yoshida S., and Terada M. A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation. Mol. Cell Biol. 15 (1995) 3664-3671
35. Itoh H., Hattori Y., Sakamoto H., Ishii H., Kishi T., Sasaki H., Yoshida T., Koono M., Sugimura T., and Terada M. Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity. Cancer Res. 54 (1994) 3237-3241
36. Matsunobu T., Ishiwata T., Yoshino M., Watanabe M., Kudo M., Matsumoto K., Tokunaga A., Tajiri T., and Naito Z. Expression of keratinocyte growth factor receptor correlates with expansive growth and early stage of gastric cancer. Int. J. Oncol. 28 (2006) 307-314
37. Shaoul E., Reich-Slotky R., Berman B., and Ron D. Fibroblast growth factor receptors display both common and distinct signaling pathways. Oncogene 10 (1995) 1553-1561
38. Kerbel R.S. Tumor angiogenesis: past, present and the near future. Carcinogenesis 21 (2000) 505-515
39. Knee R.S., Pitcher S.E., and Murphy P.R. Basic fibroblast growth factor sense (FGF) and antisense (gfg) RNA transcripts are expressed in unfertilized human oocytes and in differentiated adult tissues. Biochem. Biophys. Res. Commun. 205 (1994) 577-583
40. Coulier F., Ollendorff V., Marics I., Rosnet O., Batoz M., Planche J., Marchetto S., Pebusque M.J., deLapeyriere O., and Birnbaum D. The FGF6 gene within the FGF multigene family. Ann. NY Acad. Sci. 638 (1991) 53-61
41. Munroe S.H. Diversity of antisense regulation in eukaryotes: multiple mechanisms, emerging patterns. J. Cell Biochem. 93 (2004) 664-671
42. Lease R.A., and Belfort M. A trans-acting RNA as a control switch in Escherichia coli: DsrA modulates function by forming alternative structures. Proc. Natl. Acad. Sci. USA 97 (2000) 9919-9924
43. Tasheva E.S., and Roufa D.J. Regulation of human RPS14 transcription by intronic antisense RNAs and ribosomal protein S14 Genes. Development 9 (1995) 304-316
44. Kodera Y., Fujiwara M., Koike M., and Nakao A. Chemotherapy as a component of multimodal therapy for gastric carcinoma. World J. Gastroenterol. 12 (2006) 2000-2005